Processa Pharmaceuticals Inc (PCSA)
1.60
+0.05
(+3.23%)
USD |
NASDAQ |
Apr 23, 16:00
1.60
0.00 (0.00%)
After-Hours: 20:00
Processa Pharmaceuticals Net Income (TTM): -11.12M for Dec. 31, 2023
Net Income (TTM) Chart
Historical Net Income (TTM) Data
| Date | Value |
|---|---|
| December 31, 2023 | -11.12M |
| September 30, 2023 | -21.73M |
| June 30, 2023 | -25.67M |
| March 31, 2023 | -28.22M |
| December 31, 2022 | -27.42M |
| September 30, 2022 | -17.60M |
| June 30, 2022 | -14.56M |
| March 31, 2022 | -12.56M |
| December 31, 2021 | -11.43M |
| September 30, 2021 | -17.98M |
| June 30, 2021 | -18.06M |
| March 31, 2021 | -15.64M |
| December 31, 2020 | -14.41M |
| September 30, 2020 | -5.454M |
| June 30, 2020 | -3.246M |
| March 31, 2020 | -3.481M |
| December 31, 2019 | -3.358M |
| September 30, 2019 | -3.193M |
| June 30, 2019 | -3.182M |
| March 31, 2019 | -3.419M |
| December 31, 2018 | -3.765M |
| September 30, 2018 | -4.689M |
| June 30, 2018 | -4.041M |
| Date | Value |
|---|---|
| March 31, 2018 | -2.878M |
| December 31, 2017 | -1.856M |
| September 30, 2017 | -0.4137M |
| June 30, 2017 | -0.2776M |
| March 31, 2017 | -0.278M |
| December 31, 2016 | -0.336M |
| September 30, 2016 | -0.6079M |
| June 30, 2016 | -0.8353M |
| March 31, 2016 | -2.843M |
| December 31, 2015 | -3.354M |
| September 30, 2015 | -4.530M |
| June 30, 2015 | -5.026M |
| March 31, 2015 | -3.827M |
| December 31, 2014 | -4.526M |
| September 30, 2014 | -3.794M |
| June 30, 2014 | -3.721M |
| March 31, 2014 | -3.597M |
| December 31, 2013 | -3.069M |
| September 30, 2013 | -3.045M |
| June 30, 2013 | -2.928M |
| March 31, 2013 | -2.676M |
| December 31, 2012 | -2.440M |
Net Income Definition
Net Income is the total amount of profit earned by a company. This metric boils down to the overall profit that is left from the revenue that a company receives after taking out various operational line items like cost of goods sold, income tax expense, SG&A expense, etc. Eventually, all companies would want to have a consistent positive and growing net income, so that this can be used for various purposes like reinvesting into the company, paying off debt, and potentially paying out dividends to shareholders.
Net Income (TTM) Range, Past 5 Years
-28.22M
Minimum
Mar 2023
-3.182M
Maximum
Jun 2019
-13.60M
Average
-14.41M
Median
Dec 2020
Net Income (TTM) Benchmarks
| Panbela Therapeutics Inc | -25.25M |
| Vera Therapeutics Inc | -95.99M |
| Corbus Pharmaceuticals Holdings Inc | -44.60M |
| Ensysce Biosciences Inc | -10.63M |
| Elicio Therapeutics Inc | -33.82M |